Bausch launches new eye implant; Abiomed revenue leaps 17%;

 @FierceMedDev: FDA slaps Class I on Covidien's ventilator battery recall. News | Follow @FierceMedDev

 @MarkHFierce: Smith & Nephew nailed down some M&A in India and launched a $300M share buyback. The goal: renewed growth. Article | Follow @MarkHFierce

 @DamianFierce: St. Jude is studying its next-gen CRT-D with an eye on FDA approval. More | Follow @DamianFierce

> Bausch + Lomb has launched its Incise microincision intraocular lens in Europe, touting the device as allowing for less-invasive cataract surgery. News

> Abiomed ($ABMD) posted 17% revenue growth last quarter, posting $43.7 million in sales fueled by Impella heart pump sales. Net income came in at $3.7 million, a 42% increase. Results

> NeuroSigma won Canadian approval for its Monarch eTNS device, designed for major depressive disorder. More

> Becton Dickinson ($BDX) hauled in $2 billion revenue last quarter, a 3.7% jump, but net income declined 5.3% to $275.6 million. Financials

> Eventus Diagnostics won a CE mark for its Octava Pink breast cancer diagnostic. Release

> Cancer Genetics ($CGIX) has launched UroGenRA, a proprietary microarray for kidney cancer diagnostics. Item

> In an interview with Regulatory Focus, CDRH senior adviser Jay Crowley explains the FDA's goals in implementing a unique device identification. Article

Biotech News

 @FierceBiotech: Flemming Ornskov - The 25 most influential people in biopharma today. Profile | Follow @FierceBiotech

 @JohnCFierce: New Shire CEO Ornskov shakes up company after seizing the rein. Article | Follow @JohnCFierce

 @RyanMFierce: Gilead is trading up about 5% on Ph2 news of 95%-plus SVR rates with sofosbuvir + ledipasvir w/ & w/o ribavirin. One patient relapsed. | Follow @RyanMFierce

> Biotech Symphogen tacks on $53.7M to big venture round after Merck Serono deal. More

> Billionaire Kirk grabs $150M round for synthetic biology deals at Intrexon. News

> Merck buddies up to Scripps spinout Abide in $430M diabetes partnership. Article

> J&J grabs another 'breakthrough' FDA win with early-stage cancer drug. News

Pharma News

 @FiercePharma: Provigil generics drag Teva profits down; sales off 3.9%. Copaxone up 17%, but how long can that last w/ new MS competition? | Follow @FiercePharma

 @EricPFierce: Pharma cargo thefts spike as robbers hit pharmacy delivery van in "last-mile" attacks. Chances of violence higher. Article | Follow @EricPFierce

> Sanofi sales, profits fall short, but CEO sticks to growth promises. More

> Takeda persuades Actos judge to toss $6.5M jury verdict. News

Pharma Manufacturing News

> China sets rules for excipient makers after scandal. News

> Manufacturing issues trip up approval for Gilead, Impax. Article

> Cargo thefts spike as robbers target pharmacy deliveries. Report

> More recalls as Hospira struggles to right manufacturing. Story

Vaccines News

> H7N9 may have evolved from four origins. Item

> GSK, Sanofi vaccines proving effective in measles outbreak. Report

> U.K. vaccine expansion a boon for GSK and Merck. More

> Merck's Gardasil looks effective in two-shot regimen. Article

> Search goes on for HIV vaccine after NIH trial nixed. Story

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.